Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype which lacks the estrogen receptor (ER) and progesterone receptor (PR) expression and also lacks overexpression of the human epidermal growth factor receptor 2 (HER2). Here, PGR is linked to triple-negative breast carcinoma.